This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.
This bill (A 964) creates a 15-member "Nursing Home Emergency Preparedness Study Commission" to analyze how New Jersey nursing homes respond to public health emergencies. The commission will examine nursing home environments, emergency policies, staffing levels, and funding needs during crises, and make recommendations to improve resident safety. It includes state health and human services officials, nursing home industry representatives (appointed by legislative leaders), and family members of residents (appointed by the Governor). The commission must submit a report to the Governor and Legislature within 12 months of its first meeting and then expire. This is a procedural study bill with no immediate policy changes, focusing on future recommendations.
This bill creates a statewide stockpile of essential medicines, vaccines, and medical supplies to be managed by New Jersey's Department of Health and State Office of Emergency Management. The stockpile, funded by state appropriations, will be used during emergencies like natural disasters, disease outbreaks, or public health crises. Key provisions require the state to establish distribution guidelines prioritizing healthcare providers in rural and medically underserved areas, with supplies managed through contracts that may include vendor-managed "virtually sequestered" inventories to prevent expiration. The bill mandates demand planning to determine stockpile contents and quantities based on emergency scenarios.
This bill expands New Jersey's existing requirement for health insurance plans to cover prostate cancer screenings without any out-of-pocket costs. It specifically requires coverage for annual screenings - including digital rectal exams and PSA tests - for men aged 50 and older (asymptomatic) and men aged 40 and older with a family history of prostate cancer or other risk factors. The law applies to most health insurance plans, including high-deductible plans where permitted by federal law, and mandates coverage "to the same extent as for any other medical condition." It does not alter existing coverage for other preventive services but ensures no cost-sharing (like deductibles or copays) applies to these specific screenings.
This bill exempts drug manufacturers and distributors from New Jersey's pharmacy licensing requirements when distributing dialysate drugs and devices used for home dialysis treatment of end-stage renal disease patients. It directly affects dialysis manufacturers, distributors, and patients receiving home dialysis, allowing them to bypass standard pharmacy licensing rules under six specific conditions. Key provisions include requiring FDA approval, direct delivery only upon physician orders, original sealed packaging, and mandatory weekly quality checks by a consultant pharmacist. The law ensures these products are handled safely while streamlining access for patients needing home dialysis.
This New Jersey bill creates a new crime called fertility fraud, which specifically targets licensed health care practitioners who knowingly use a patient's reproductive material without their written consent. Under the law, a practitioner commits this offense if they use their own sperm or eggs or the material of another person to cause a pregnancy without the patient's informed agreement. If convicted of this third-degree crime, the individual faces up to five years in prison, a fine of $15,000, and the mandatory permanent revocation of their medical license. Additionally, the legislation extends the statute of limitations for prosecuting this specific offense to 20 years from the date of the treatment or 10 years from when the victim discovers the fraud, whichever is later.
This bill requires state agencies to assess substance and alcohol use disorder treatment providers for conflicts of interest before approving state funding, licensure, or certification. Providers must submit detailed financial information, board member details, and lists of stakeholders with financial ties. If a conflict is identified that could affect care quality, the provider has 90 days to resolve it or risk losing funding/approval. After resolution, providers must undergo two additional conflict assessments within the next year. The law applies to all licensed or certifying state entities and defines conflicts as situations where outside financial interests might influence treatment decisions.
This bill prohibits the $0.50 surcharge on rideshare trips that are designated for paratransit service, which includes transportation for people with disabilities and Medicaid non-emergency medical transport. It directly affects users of apps like Uber and Lyft who rely on these services for accessibility needs, ensuring they are not charged the extra fee required for regular prearranged rides. The legislation also clarifies that transportation network companies are not personally liable for these specific paratransit trips. By amending existing state laws, the bill removes the financial barrier for eligible riders while maintaining the surcharge for standard rides.
This bill requires New Jersey's Department of Health (DOH) to create and maintain a comprehensive Statewide Emergency Medical Services (EMS) Plan. The plan must include resource inventories, performance metrics to improve response times and access, regional coordination with county health boards, and specific goals like reducing patient treatment delays and designating trauma centers. It mandates triennial updates and public availability of the plan online, while also addressing training, disaster response teams, and mental health support for EMS personnel. The law directly affects all emergency medical services providers, hospitals, and 911 dispatch centers across New Jersey by setting statewide standards for system coordination and performance.
This bill requires all New Jersey municipalities to provide basic life support (BLS) ambulance services to meet community needs, designating BLS as an essential service. It specifies five ways municipalities can arrange these services: licensing private companies, contracting with public/private entities, creating mutual aid agreements with other towns, partnering with hospitals, or using existing fire/EMS departments. The law defines BLS as pre-hospital care including CPR, wound stabilization, and emergency transport. This policy change ensures consistent access to emergency medical care across the state by making BLS a mandatory municipal responsibility.
